Definium Therapeutics Ownership | Who Owns Definium Therapeutics?
Definium Therapeutics Ownership Summary
Definium Therapeutics is owned by 106.41% institutional investors, 1.73% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.64% of DFTX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.63% of its assets in Definium Therapeutics shares.
DFTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Definium Therapeutics | 106.41% | 1.73% | -8.13% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 11.77M | 10.64% | $448.06M |
| Fmr | 9.08M | 8.21% | $345.67M |
| Capital world investors | 8.26M | 7.46% | $314.21M |
| Avoro capital advisors | 7.19M | 6.61% | $338.17M |
| Driehaus capital management | 6.85M | 6.29% | $322.00M |
| Price t rowe associates inc /md/ | 4.65M | 4.28% | $218.83M |
| Geode capital management | 3.64M | 3.29% | $138.75M |
| State street | 3.30M | 2.98% | $125.64M |
| Octagon capital advisors lp | 2.95M | 2.71% | $138.77M |
| Wellington management group llp | 2.95M | 2.71% | $138.76M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Octagon capital advisors lp | 2.95M | 12.47% | $138.77M |
| Data collective iv gp | 100.35K | 6.01% | $4.72M |
| Commodore capital lp | 2.00M | 5.60% | $94.08M |
| Superstring capital management lp | 188.28K | 5.59% | $8.86M |
| Catalio capital management, lp | 562.67K | 4.97% | $26.47M |
| Great point partners | 425.00K | 3.78% | $19.99M |
| Boxer capital management | 998.50K | 3.54% | $46.97M |
| Avoro capital advisors | 7.19M | 3.04% | $338.17M |
| Awm investment company | 764.80K | 2.80% | $29.11M |
| Patient square capital lp | 385.00K | 2.34% | $14.65M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 4.65M | 0.02% | 4.58M |
| Fmr | 9.08M | 0.01% | 4.33M |
| Capital world investors | 8.26M | 0.04% | 2.89M |
| Avoro capital advisors | 7.19M | 3.04% | 2.19M |
| Alliancebernstein | 1.80M | 0.01% | 1.71M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Siren | - | - | -1.42M |
| Sixth street partners management company | - | - | -1.08M |
| Arrowmark colorado | 564.07K | 1.10% | -1.03M |
| Marshall wace, llp | 491.03K | 0.02% | -807.92K |
| Millennium management | 266.08K | 0.00% | -580.82K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 1.50M | 0.61% | 1.50M | $70.56M |
| Lord, abbett | 958.63K | 0.11% | 958.63K | $36.49M |
| Polar capital | 777.25K | 0.09% | 777.25K | $36.56M |
| Bamco inc /ny/ | 520.11K | 0.04% | 520.11K | $24.47M |
| Great point partners | 425.00K | 3.78% | 425.00K | $19.99M |
Sold Out
| Holder | Change |
|---|---|
| Corecap advisors | -5.00 |
| Gilpin wealth management | -6.00 |
| Comprehensive financial planning, inc./pa | -8.00 |
| Ares financial consulting | -8.00 |
| Covestor | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 384 | 47.69% | 115,759,808 | 48.34% | 106 | 2.07% | 268 | 9.39% | 66 | 1550.00% |
| Mar 31, 2026 | 253 | 3062.50% | 73,974,924 | 557.41% | 82 | 52.19% | 238 | 2875.00% | 4 | - |
| Dec 31, 2025 | 8 | - | 11,252,538 | - | 12 | - | 8 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 10.25M | 7.63% | 2.56M |
| iShares Russell 2000 ETF | 3.17M | 2.36% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.49M | 1.11% | 7.68K |
| Fidelity Small Cap Index | 1.42M | 1.06% | 2.03K |
| Vanguard Health Care Inv | 1.27M | 0.94% | 527.23K |
| iShares Russell 2000 Growth ETF | 1.18M | 0.88% | -4.46K |
| US Small-Cap Growth II Equity Comp | 1.14M | 0.86% | 1.14M |
| T. Rowe Price New Horizons | 1.13M | 0.84% | -85.50K |
| iShares Biotechnology ETF | 996.28K | 0.74% | -4.93K |
| T. Rowe Price Integrated US Sm Gr Eq | 901.49K | 0.67% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Karlin Daniel | Chief Medical Officer | Sell | $396.89K |
| Sep 25, 2026 | Barrow Robert | Chief Executive Officer | Sell | $1.15M |
| Sep 25, 2026 | Wiley Matthew T. | Chief Commercial Officer | Sell | $113.26K |
| Sep 25, 2026 | Sullivan Mark | Chief Legal Officer | Sell | $513.85K |
| Sep 25, 2026 | Roberts Brandi | Chief Financial Officer | Sell | $123.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | - | 5 |
| 2026 Q1 | - | 3 |
DFTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools